Safety Monitoring Strategies for Pediatric and Geriatric Clinical Trials
Safety Monitoring Strategies for Pediatric and Geriatric Clinical Trials Optimizing Safety Monitoring for Pediatric and Geriatric Clinical Trials Why Safety Monitoring Must be Age-Specific Safety monitoring in clinical trials is not a one-size-fits-all process. Pediatric and geriatric populations exhibit distinct physiological, metabolic, and immunological characteristics that influence how they respond to investigational products. In pediatrics,…
Read More “Safety Monitoring Strategies for Pediatric and Geriatric Clinical Trials” »